Why are we failing to implement effective therapies in cardiovascular disease?
about
Mobile phone text messaging to improve adherence to cardiovascular disease secondary prevention interventionsPrecision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular diseaseResource Effective Strategies to Prevent and Treat Cardiovascular DiseaseTowards understanding the de-adoption of low-value clinical practices: a scoping reviewThe Danish Cardiac Rehabilitation DatabaseWeb-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-AnalysisMelatonin has multiorgan effectsDelivery of health care for cardiovascular and metabolic diseases among people living with HIV/AIDS in African countries: a systematic review protocolMobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease.Meta-regression analyses to explain statistical heterogeneity in a systematic review of strategies for guideline implementation in primary health care.The Contribution of Individual Exercise Training Components to Clinical Outcomes in Randomised Controlled Trials of Cardiac Rehabilitation: A Systematic Review and Meta-regression.A multifaceted quality improvement intervention for CVD risk management in Australian primary healthcare: a protocol for a process evaluationEULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: an audit of the success of implementation in a rheumatology outpatient clinic.Determinants of adherence to treatment in hypertensive patients of African descent and the role of culturally appropriate education.Effectiveness of implementation strategies in improving physician adherence to guideline recommendations in heart failure: a systematic review protocolPractice change in chronic conditions care: an appraisal of theoriesEnablers and barriers for implementing high-quality hypertension care in a rural primary care setting in Nigeria: perspectives of primary care staff and health insurance managers.Impact of Clinical Guideline Recommendations on the Application of Coronary Computed Tomographic Angiography in Patients with Suspected Stable Coronary Artery Disease.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies.Dabigatran for the treatment of venous thromboembolism.Competency-based medical education and continuing professional development: A conceptualization for change.Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials.Potential factors associated with fruit and vegetable intake after premature acute coronary syndrome: a prospective cohort study.Impact of electronic clinical decision support on adherence to guideline-recommended treatment for hyperlipidaemia, atrial fibrillation and heart failure: protocol for a cluster randomised trial.[Knowledge of guidelines for anticoagulation management of patients with atrial fibrillation].Challenges in secondary prevention after acute myocardial infarction: A call for action.Challenges in secondary prevention after acute myocardial infarction: A call for action.Does standardization improve care or stifle innovation?Changing behaviour 'more or less'-do theories of behaviour inform strategies for implementation and de-implementation? A critical interpretive synthesisCoronary calcium score improves the estimation for pretest probability of obstructive coronary artery disease and avoids unnecessary testing in individuals at low extreme of traditional risk factor burden: validation and comparison of CONFIRM score aWhat drives adoption of a computerised, multifaceted quality improvement intervention for cardiovascular disease management in primary healthcare settings? A mixed methods analysis using normalisation process theory
P2860
Q24188063-336C8F43-B451-41B5-B2E0-570420FD7D1CQ26747071-2A857092-7FFA-42BF-B1B1-84395CDDC601Q26768304-970CC748-CA18-4AEC-ABF5-32A63C8BC3EFQ26786656-89835530-D6B4-4452-AAB7-C41718FE3447Q28069905-BE96556A-C1B9-4FC4-80EB-737C8DD630ABQ28072511-CFCA34FA-DD39-46CF-9546-D7CECEF5F296Q28077901-4FF09759-B2E4-4CE3-AC8A-F37561E6730AQ28392380-F7E3F1FB-8DC1-4828-837C-38CDF41616FBQ30234608-2FC2CB2F-38A0-487B-AA7B-E8A088EE1AF7Q30317003-5C3BB8C7-1BD9-4C30-B9C1-556CCAFE2014Q33644281-4D02A841-98B8-4E49-BF76-30D42D7FA26FQ34788667-2D5DABB6-E139-4A45-AAAA-F8F6BA82AA08Q35177998-FB89408B-37A0-4C2F-8668-90B7585D64DDQ35743976-B05EECBD-07A5-426B-9515-D06F73D39DC6Q35976076-160A9CA6-6085-4378-B6D7-C0537C206095Q36293164-2AFD7B92-29D5-462B-822D-98963C625462Q36581344-30B8ABA0-A747-4D41-8674-68053DA6565BQ36705431-046BC78E-3B26-4F6E-8DF1-437F8AB1A8DBQ37254899-F03D0698-9DDB-41E2-B62F-BFC488C3CF9DQ37483643-4DCED5DA-E356-4B1A-B342-AF93086C4433Q38537977-8DE01998-E37D-4897-BB4A-CFC3E251CEF5Q38734176-3BF4E9F1-0964-4B42-B2EF-D9860B92A7D5Q38774887-0F688401-8E69-4429-8314-8A1E9E917AD3Q40361904-CEA24990-68B5-42D7-B915-D33DB1726796Q47098511-FCEEABB2-84D6-4E0C-92C8-93094C33182CQ51276277-5333772F-0C26-41FB-90BE-8AE478EA8AB0Q52838141-AF1F976F-0042-47BC-833C-4F6E757CE8A3Q52847951-F33567DD-F8C1-4634-93AB-1394579E8622Q53163261-38F9059D-B373-4D2E-A999-2CC9CCB9061FQ58103338-506D5C10-CE21-484F-8544-D7B7C755C017Q58696029-3406D097-6AB0-47A0-A9EF-BD31F828BBABQ59127434-4C891C76-E11F-4AB7-81B8-F638C78C4263
P2860
Why are we failing to implement effective therapies in cardiovascular disease?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Why are we failing to implement effective therapies in cardiovascular disease?
@en
type
label
Why are we failing to implement effective therapies in cardiovascular disease?
@en
prefLabel
Why are we failing to implement effective therapies in cardiovascular disease?
@en
P2093
P2860
P356
P1476
Why are we failing to implement effective therapies in cardiovascular disease?
@en
P2093
Jon-David Schwalm
Rasha Khatib
Robby Nieuwlaat
P2860
P304
P356
10.1093/EURHEARTJ/EHS481
P50
P577
2013-02-01T00:00:00Z